Israel Englander Medical Devices

Millennium Management LLC

$175 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
BSX Boston Scientific Corp	$150B	$842 Million 0.48% of portfolio	8,344,156	Q1 2025 Reduced 8.59%
EW Edwards Lifesciences Corp	$47.1B	$250 Million 0.14% of portfolio	3,444,764	Q1 2025 Added 1,409.76%
ALGN Align Technology Inc	$15B	$142 Million 0.08% of portfolio	896,929	Q1 2025 Reduced 20.33%
ABT Abbott Laboratories	$211B	$90 Million 0.05% of portfolio	678,720	Q1 2025 Added 18.63%
MDT Medtronic PLC	$119B	$83.4 Million 0.05% of portfolio	928,239	Q1 2025 Reduced 40.07%
BIO Bio Rad Laboratories, Inc.	$6.15B	$81.8 Million 0.05% of portfolio	336,052	Q1 2025 Reduced 11.35%
LIVN Liva Nova PLC	$2.28B	$81.1 Million 0.05% of portfolio	2,065,023	Q1 2025 Reduced 32.27%
ZBH Zimmer Biomet Holdings, Inc.	$19.9B	$76.5 Million 0.04% of portfolio	676,106	Q1 2025 Added 378.41%
PODD Insulet Corp	$19.7B	$70.8 Million 0.04% of portfolio	269,716	Q1 2025 Added 70.57%
SNN Smith & Nephew PLC	$13B	$44.4 Million 0.03% of portfolio	1,564,461	Q1 2025 Reduced 54.33%
IRTC I Rhythm Technologies, Inc.	$4.08B	$41.8 Million 0.02% of portfolio	399,746	Q1 2025 Added 563.84%
PEN Penumbra Inc	$8.72B	$39.7 Million 0.02% of portfolio	148,564	Q1 2025 Added 4,353.36%
STE Steris PLC	$22.5B	$32.3 Million 0.02% of portfolio	142,312	Q1 2025 Added 205.91%
PRCT Procept Bio Robotics Corp	$2.63B	$31.6 Million 0.02% of portfolio	542,987	Q1 2025 Added 88.64%
PHG Koninklijke Philips Nv	$21.8B	$26.2 Million 0.01% of portfolio	1,033,136	Q1 2025 Added 4.88%
DXCM Dexcom Inc	$32.5B	$23.7 Million 0.01% of portfolio	346,538	Q1 2025 Reduced 88.73%
RXST Rx Sight, Inc.	$204M	$22.7 Million 0.01% of portfolio	897,846	Q1 2025 Reduced 10.89%
UFPT Ufp Technologies Inc	$1.76B	$18.9 Million 0.01% of portfolio	93,773	Q1 2025 Added 123.1%
KIDS Orthopediatrics Corp	$519M	$16.2 Million 0.01% of portfolio	656,578	Q1 2025 Added 55.33%
FNA Paragon 28, Inc.	$1B	$14.6 Million 0.01% of portfolio	1,115,290	Q1 2025 Added 220.2%
ITGR Integer Holdings Corp	$3.8B	$14.5 Million 0.01% of portfolio	123,132	Q1 2025 Added 2,408.8%
SYK Stryker Corp	$147B	$10.5 Million 0.01% of portfolio	28,074	Q1 2025 Reduced 61.88%
IART Integra Lifesciences Holdings Corp	$1B	$9.21 Million 0.01% of portfolio	418,976	Q1 2025 Added 1,809.04%
CLPT Clear Point Neuro, Inc.	$279M	$8.81 Million 0.01% of portfolio	741,193	Q1 2025 Added 156.34%
BFLY Butterfly Network, Inc.	$320M	$8.63 Million 0.0% of portfolio	3,784,107	Q1 2025 Added 75.11%
BRKR Bruker Corp	$6.25B	$8.44 Million 0.0% of portfolio	202,302	Q1 2025 New
AVNS Avanos Medical, Inc.	$541M	$7.85 Million 0.0% of portfolio	547,740	Q1 2025 Added 508.35%
GKOS Glaukos Corp	$4.71B	$7.7 Million 0.0% of portfolio	78,232	Q1 2025 Reduced 80.1%
ZIMV Zim Vie Inc.	$267M	$7.64 Million 0.0% of portfolio	707,771	Q1 2025 Added 7.73%
SRDX Surmodics Inc	$429M	$6.3 Million 0.0% of portfolio	206,487	Q1 2025 Added 71.58%
DCTH Delcath Systems, Inc.	$99.3M	$5.37 Million 0.0% of portfolio	422,066	Q1 2025 Added 34.13%
VREX Varex Imaging Corp	$313M	$5.29 Million 0.0% of portfolio	455,959	Q1 2025 Reduced 33.73%
ELMD Electromed, Inc.	$161M	$4.64 Million 0.0% of portfolio	194,519	Q1 2025 Added 362.71%
CERS Cerus Corp	$243M	$4.48 Million 0.0% of portfolio	3,222,327	Q1 2025 Added 11.97%
TNDM Tandem Diabetes Care Inc	$986M	$4.36 Million 0.0% of portfolio	227,585	Q1 2025 Added 50.38%
CVRX Cv Rx, Inc.	$172M	$3.98 Million 0.0% of portfolio	325,389	Q1 2025 Reduced 19.66%
AORT Artivion, Inc.	$1.24B	$3.94 Million 0.0% of portfolio	160,318	Q1 2025 Reduced 3.12%
MXCT Maxcyte, Inc.	$219M	$3.76 Million 0.0% of portfolio	1,378,329	Q1 2025 Reduced 49.71%
TMCI Treace Medical Concepts, Inc.	$321M	$3.73 Million 0.0% of portfolio	444,887	Q1 2025 Added 35.32%
IRMD Iradimed Corp	$722M	$3.68 Million 0.0% of portfolio	70,147	Q1 2025 Added 59.24%
ATEC Alphatec Holdings, Inc.	$1.11B	$3.4 Million 0.0% of portfolio	335,039	Q1 2025 Reduced 68.51%
NPCE Neuro Pace Inc	$226M	$3.3 Million 0.0% of portfolio	268,716	Q1 2025 Reduced 58.22%
SIBN Si Bone, Inc.	$574M	$3.22 Million 0.0% of portfolio	229,553	Q1 2025 New
MYO Myomo, Inc.	$14.6M	$2.94 Million 0.0% of portfolio	611,769	Q1 2025 Added 404.92%
BVS Bioventus Inc.	$400M	$2.65 Million 0.0% of portfolio	289,158	Q1 2025 Reduced 22.01%
PACB Pacific Biosciences Of California, Inc.	$313M	$2.6 Million 0.0% of portfolio	2,204,044	Q1 2025 Reduced 87.08%
INSP Inspire Medical Systems, Inc.	$3.68B	$2.59 Million 0.0% of portfolio	16,246	Q1 2025 Added 221.64%
TCMD Tactile Systems Technology Inc	$202M	$2.36 Million 0.0% of portfolio	178,435	Q1 2025 Added 9.43%
CTKB Cytek Biosciences, Inc.	$444M	$1.99 Million 0.0% of portfolio	495,437	Q1 2025 Reduced 38.37%
NVRO Nevro Corp	$207M	$1.93 Million 0.0% of portfolio	331,014	Q1 2025 Reduced 0.02%

Shares Options

Israel Englander

Israel Englander is the founder and CEO of Millennium Management, a successful investment firm that uses technology and data-driven approaches to investing. Englander is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.

Track Israel Englander's portfolio

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account